On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Showing posts with label RWE/RWD. Show all posts
Showing posts with label RWE/RWD. Show all posts
Friday, November 29, 2024

Real world data (RWD) and Real world evidence (RWE) in Drug Development

›
The 21st Century Cures Act (Cures Act) , signed into law on December 13, 2016, is designed to accelerate medical product development and bri...
Sunday, May 22, 2022

The Use of External Controls in FDA Regulatory Decision Making and Bayesian Borrowing

›
An good article by Jahanshahi et al "The Use of External Controls in FDA Regulatory Decision Making". The authors reviewed and su...
Monday, January 04, 2021

Synthetic Control Arm (SCA), External Control, Historical Control

›
Lately, the term 'synthetic control' or 'synthetic control arm' or SCA, in short, is becoming popular - it is mainly driven ...
1 comment:
Monday, October 26, 2020

Real World Evidence in Regulatory Submissions - Story of IBRANCE for male breast cancer

›
In April 2019, FDA approved Pfizer's IBRANCE for male breast cancer . The approval is for the label extension for an already produce bas...
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.